Daniel Joseph Oconnell - Net Worth and Insider Trading

Daniel Joseph Oconnell Net Worth

The estimated net worth of Daniel Joseph Oconnell is at least $2 Million dollars as of 2024-11-05. Daniel Joseph Oconnell is the President and CEO of Acumen Pharmaceuticals Inc and owns about 502,485 shares of Acumen Pharmaceuticals Inc (ABOS) stock worth over $2 Million. Details can be seen in Daniel Joseph Oconnell's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel Joseph Oconnell has not made any transactions after 2024-01-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Daniel Joseph Oconnell

To

Daniel Joseph Oconnell Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daniel Joseph Oconnell owns 1 companies in total, including Acumen Pharmaceuticals Inc (ABOS) .

Click here to see the complete history of Daniel Joseph Oconnell’s form 4 insider trades.

Insider Ownership Summary of Daniel Joseph Oconnell

Ticker Comapny Transaction Date Type of Owner
ABOS Acumen Pharmaceuticals Inc 2024-01-19 director & President and CEO

Daniel Joseph Oconnell Latest Holdings Summary

Daniel Joseph Oconnell currently owns a total of 1 stock. Daniel Joseph Oconnell owns 502,485 shares of Acumen Pharmaceuticals Inc (ABOS) as of January 19, 2024, with a value of $2 Million.

Latest Holdings of Daniel Joseph Oconnell

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ABOS Acumen Pharmaceuticals Inc 2024-01-19 502,485 3.00 1,507,455

Holding Weightings of Daniel Joseph Oconnell


Daniel Joseph Oconnell Form 4 Trading Tracker

According to the SEC Form 4 filings, Daniel Joseph Oconnell has made a total of 1 transactions in Acumen Pharmaceuticals Inc (ABOS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Acumen Pharmaceuticals Inc is the sale of 15,200 shares on January 19, 2024, which brought Daniel Joseph Oconnell around $52,744.

Insider Trading History of Daniel Joseph Oconnell

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Daniel Joseph Oconnell Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Daniel Joseph Oconnell Ownership Network

Ownership Network List of Daniel Joseph Oconnell

No Data

Ownership Network Relation of Daniel Joseph Oconnell

Insider Network Chart

Daniel Joseph Oconnell Owned Company Details

What does Acumen Pharmaceuticals Inc do?

Who are the key executives at Acumen Pharmaceuticals Inc?

Daniel Joseph Oconnell is the director & President and CEO of Acumen Pharmaceuticals Inc. Other key executives at Acumen Pharmaceuticals Inc include Chief Legal Office & Corp Sec Derek M Meisner , Chief Financial Officer Matt Zuga , and Chief Medical Officer Eric Siemers .

Acumen Pharmaceuticals Inc (ABOS) Insider Trades Summary

Over the past 18 months, Daniel Joseph Oconnell made 1 insider transaction in Acumen Pharmaceuticals Inc (ABOS) with a net sale of 15,200. Other recent insider transactions involving Acumen Pharmaceuticals Inc (ABOS) include a net purchase of 5,161,290 shares made by Ra Capital Healthcare Fund Lp , a net sale of 41,949 shares made by Jeffrey L. Ives , and a net sale of 8,933 shares made by Derek M Meisner .

In summary, during the past 3 months, insiders sold 0 shares of Acumen Pharmaceuticals Inc (ABOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 76,281 shares of Acumen Pharmaceuticals Inc (ABOS) were sold and 5,161,290 shares were bought by its insiders, resulting in a net purchase of 5,085,009 shares.

Acumen Pharmaceuticals Inc (ABOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Acumen Pharmaceuticals Inc Insider Transactions

No Available Data

Daniel Joseph Oconnell Mailing Address

Above is the net worth, insider trading, and ownership report for Daniel Joseph Oconnell. You might contact Daniel Joseph Oconnell via mailing address: C/o Acumen Pharmaceuticals, Inc., 427 Park Street, Charlottesville Va 22902.